Feingold syndrome

From WikiMD's WELLNESSPEDIA

(Redirected from MMT syndrome)

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC

Feingold syndrome
Synonyms Oculodigitoesophagoduodenal syndrome
Pronounce
Specialty Medical genetics
Symptoms Microcephaly, digital anomalies, esophageal atresia, duodenal atresia
Complications N/A
Onset Congenital
Duration Lifelong
Types N/A
Causes Genetic mutation in the MYCN gene
Risks Family history of the condition
Diagnosis Genetic testing, clinical evaluation
Differential diagnosis VACTERL association, CHARGE syndrome
Prevention N/A
Treatment Symptomatic treatment, surgical intervention
Medication
Prognosis Variable, depending on severity of symptoms
Frequency Rare
Deaths


Feingold syndrome is a rare genetic disorder characterized by a combination of physical abnormalities and developmental delays. It is also known as Oculodigitoesophagoduodenal syndrome. The syndrome is named after Dr. Murray Feingold, who first described the condition.

Presentation[edit]

Individuals with Feingold syndrome typically present with a range of congenital anomalies. Common features include:

Genetics[edit]

Feingold syndrome is primarily caused by mutations in the MYCN gene, which plays a crucial role in cell growth and development. The condition is inherited in an autosomal dominant manner, meaning that only one copy of the mutated gene is necessary for the disorder to be present.

Diagnosis[edit]

Diagnosis of Feingold syndrome is based on clinical evaluation, identification of characteristic physical features, and genetic testing to confirm mutations in the MYCN gene. Prenatal diagnosis may be possible through genetic testing if there is a known family history of the disorder.

Management[edit]

There is no cure for Feingold syndrome, and treatment is symptomatic and supportive. Management may involve:

  • Surgical correction of esophageal atresia and duodenal atresia
  • Physical therapy and occupational therapy to address developmental delays
  • Special education services to support learning disabilities

Epidemiology[edit]

Feingold syndrome is a rare condition, and its exact prevalence is unknown. It affects both males and females equally.

See also[edit]

See also[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.